查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197851

骨科生物材料市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Orthopedic Biomaterials Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

骨科生物材料市场预计在 2022-2027 年的预测期内復合年增长率为 7.5%。

由于 2020 年全国封锁，私人和公共交通受到限制，减少了交通事故和伤害。 因此，医疗机构的重点从手术转移到 COVID-19 患者，这在大流行的早期阶段对市场产生了短期影响，特别是在专科医院。 此外，世界各地的骨科中心和医院已经关闭或在资源有限的情况下运营，其他医院已转变为收容设施和治疗 COVID-19 患者的单位。 例如，2020 年 8 月发表的一篇题为“Impact of COVID-19 in Orthopaedic Surgery. Experience from Saudi Arabia”的研究论文指出，骨科住院医师培训因 COVID-19 大流行而增加。 所有择期手术的不可避免的暂停限制了一些程序的实践和经验。 因此，这些因素在 COVID-19 大流行期间对骨科生物材料的需求产生了重大影响。

此外，运动损伤的增加、意外创伤病例数的增加以及关节重建和关节成形术等骨科手术的增加也对骨科生物材料产生了大量需求。我们正在推动增长的材料市场。

老年人口的增长、肌肉骨骼损伤发生率的增加以及选择膝关节置换、结构和其他关节相关骨科手术的患者数量的增加预计将推动市场增长。预计。 根据联合国经济和社会事务部《世界老龄化人口：2020 年亮点》，2020 年 65 岁及以上人口将达到 7.27 亿，预计到 2050 年将翻一番，达到 15 亿。 随着世界范围内越来越多的老年人口变得更容易出现关节问题，从而更容易发生手术，预计未来几年骨科□□生物材料的采用将会增加。 此外，根据世界卫生组织 2022 年 7 月的更新，全球约有 17.1 亿人患有肌肉骨骼疾病。 如此高的肌肉骨骼疾病负担导致肌肉骨骼损伤的增加，这推动了骨科生物材料的市场增长。

此外，该领域的进展也在推动市场增长。 例如，2020 年 9 月，赢创为医疗技术市场开发了一种新型骨传导聚醚醚酮 (PEEK)，可改善骨植入物融合。

因此，上述因素预计将在整个分析期间推动市场增长。 然而，缺乏与该程序相关的报销政策可能会在一定程度上阻碍市场增长。

骨科生物材料的市场趋势

骨科生物材料的陶瓷&生物活性玻璃板块未来有望实现健康增长。

按材料类型划分的陶瓷和生物活性玻璃细分市场预计未来将呈现健康增长。 这是由于越来越多地采用脊柱手术和椎间融合术。 此外，融合手术中合成融合器和椎弓根螺钉的兴起正在推动这一领域的增长。 合成融合器和椎弓根螺钉可维持符合条件的患者的稳定性并提高同种异体移植物融合率。

多项体外和体内研究评估了陶瓷和生物活性玻璃作为骨科生物材料的改进生物相容性、生物降解性和骨整合。 例如，在 2020 年 2 月 BMC（S□□pringer Nature 的一部分）上发表的论文“骨科生物材料：免疫调节的过去和未来”中，第一代陶瓷与週期性组件损坏有关。然而，在韩国，第二代新一代生物惰性陶瓷，即氧化锆增强氧化铝，已被广泛使用，并在很大程度上取代了超高分子量聚乙烯（UHMWPE），成为全髋关节置换术的首选材料。据说有 这些材料有望始终用于关节置换手术。 因此，骨科手术中陶瓷的高效率和玻璃材料的生物利用度有望推动这一领域的增长。

此外，2022 年 2 月，Orthofix Medical 推出了 Opus BA，这是一种合成的生物活性骨移植液，混合了碳酸磷灰石骨矿物质、生物活性玻璃和 1 型胶原蛋白载体，用于颈椎和腰椎融合手术。。 作为支架，Opus BA 允许骨骼在表面生长，并在癒合过程中被吸收以替代天然骨骼。 此类发布正在推动细分市场的增长。

因此，由于上述因素，市场预计在预测期内会出现增长。

北美占据了很大的市场份额，预计在预测期内也会如此

北美是全球骨科生物材料市场的主要参与者，因为其目标人群不断增长，人口老龄化速度加快，与骨科相关的先进产品采用率高，并且存在众多与骨科相关的製药公司。预计将占据市场份额。 根据 Rural Health Information Hub 2020 报告，美国 65 岁及以上的人口超过 4600 万，到 2050 年这一数字预计将增长到近 9000 万。 此外，预计 2020 年至 2030 年间老年人口将增加近 1800 万。 因此，由于骨关节炎和骨质疏鬆症等疾病的患病率增加，严重损害老年人的福祉，预计该国不断增长的老年人口将推动研究目标市场的发展。

美国在北美地区的骨科生物材料市场占有最大份额。 此外，美国医疗基础设施的改善、医疗成本的上升以及运动损伤的高频率正在推动市场增长。 同样，2020 年 3 月，全国骨科和假肢促进协会 (NAAOP) 宣布，美国州和地方卫生官员应确保在大流行期间需要骨科和假肢护理的患者将继续获得医疗服务。他警告说，骨科和假肢和矫形器应被视为必须提供的基本服务。 这种发展导致该地区骨科手术的增加，在大流行阶段增加了对生物材料的需求。

此外，监管部门的批准也在推动市场增长。 例如，2022 年 6 月，Ceramtech 的一种新型陶瓷全膝关节置换装置获得了美国食品和药物管理局颁发的突破性装置称号。 此类批准正在推动市场增长。

因此，由于上述因素，该地区的市场预计会出现增长。

骨科生物材料市场竞争者分析

骨科生物材料市场竞争适中，由几家大型企业组成。 目前主导市场的公司包括 Koninklijke DSM N.V.、Zimmer Biomet、Stryker、Invibio Ltd.、Evonik Industries、DePuy Synthes、Cam Bioceramics、Exactech, Inc 和 Globus Medical Inc。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 老年人口比例增加
    • 肌肉骨骼损伤的发生率增加
  • 市场製约因素
    • 保险报销政策
  • 五力分析分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（金额基础：百万美元）

  • 按材料类型
    • 高分子材料
    • 陶瓷/生物活性玻璃
    • 磷酸钙骨水泥
    • 金属
    • 其他
  • 通过使用
    • 骨科
    • 关节成形术/重建
    • 关节内置换疗法
    • 骨科植入物
    • 其他
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Koninklijke DSM N.V.
    • Zimmer Biomet
    • Stryker
    • Invibio Ltd.
    • Evonik Industries
    • DePuy Synthes
    • Cam Bioceramics
    • Exactech, Inc
    • Globus Medical Inc

第7章 市场机会与今后动向

简介目录
Product Code: 69676

The Orthopedic Biomaterials Market is expected to register a CAGR of 7.5% during the forecast period, 2022-2027.

Due to nationwide lockdowns in 2020, private and public transportation were restricted, resulting in fewer road accidents and injuries. As a result, the focus of the healthcare facilities switched from surgical procedures to COVID-19 patients, which had a short-term impact on the market in the initial pandemic phase, particularly in specialized hospitals. In addition, orthopedic centers and hospitals worldwide were closed or were operating with limited resources, while other hospitals were transformed into containment facilities and treatment units for COVID-19 patients. For instance, the research article published in August 2020, titled "Impact of COVID-19 on orthopedic surgery: Experience from Saudi Arabia", stated that orthopedic residency training was adversely affected by the COVID-19 pandemic. The inevitable pausing of all elective surgeries has limited hands-on practice and exposure to several procedures. Thus, such factors greatly impacted the demand for orthopedic biomaterials during the COVID-19 pandemic globally.

Moreover, the rising number of sports injuries, an increasing number of cases of trauma from accidents, and growing orthopedic surgeries like joint reconstruction and joint arthroplasty are also creating a massive demand for orthopedic biomaterials, thus driving the growth of the orthopedic biomaterial market.

The rising geriatric population, growing incidences of musculoskeletal injuries, and rising numbers of patients opting for knee replacement, construction, and other joint-related orthopedic procedures are expected to drive market growth. According to the United Nations Department of Economic and Social Affairs, World Ageing Population: 2020 Highlights, there were 727 million people aged 65 or older in 2020, which is expected to double and reach 1.5 billion by 2050. As the growing geriatric population worldwide is more susceptible to joint problems and ultimately surgeries, the adoption of orthopedic biomaterials is likely to increase over the coming years. Additionally, according to the World Health Organization's update of July 2022, approximately 1.71 billion people have musculoskeletal conditions worldwide. Such a high burden of musculoskeletal conditions results in increased musculoskeletal injuries, which in turn drives the growth of the market for orthopedic biomaterials.

Furthermore, the advancements in the field are also propelling the growth of the market. For instance, in September 2020, Evonik developed a new osteoconductive polyether ether ketone (PEEK) for the medical technology market that improves the fusion between bone and an implant.

Thus, the aforementioned factors are expected to boost the growth of the market throughout the analysis period. However, the lack of reimbursement policies associated with the procedures may hamper the market's growth to a certain extent.

Orthopedic Biomaterials Market Trends

The Ceramics & Bioactive Glasses Segment in Orthopedic biomaterial is Estimated to Witness a Healthy Growth in Future.

The ceramics & bioactive glasses segment by material type is estimated to witness healthy growth in the future. This is attributed to the increasing adoption of several spine surgeries and interbody fusion procedures. In addition, an increase in synthetic cages and pedicle screws during fixation procedures drives the segment growth. Synthetic cages and pedicle screws maintain stability in the target patient pool and increase allograft fusion rates.

Several in vitro and in vivo studies have evaluated the biocompatibility, biodegradability, and improved osseointegration of ceramics and bioactive glasses as orthopedic biomaterials. For instance, the article titled "Biomaterials in orthopaedics: the past and future with immune modulation" published in BMC (Part of Springer Nature) in February 2020, stated that while first-generation ceramics were accompanied by regular component damage, the second-generation bioinert ceramics, namely alumina augmented with zirconia, are extensively used in Korea and have almost replaced ultra-high molecular weight polyethylene (UHMWPE) as the material of choice in total hip arthroplasty. These materials are anticipated to be used constantly for joint replacement. Thus, higher efficiency of the ceramic and bioavailability of glass material in orthopedic procedures are expected to boost the segment's growth.

Additionally, in February 2022, Orthofix Medical launched a synthetic bioactive bone graft solution, Opus BA, a mix of carbonate apatite bone mineral, bioactive glass, and Type 1 collagen carrier for cervical and lumbar spine fusion procedures. Acting as a scaffold, Opus BA allows the bone to grow across the surface and is reabsorbed and replaced with a natural bone while healing. Such launches are propelling the growth of the market segment.

Thus, owing to the abovementioned factors, the market segment is expected to show growth over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a significant market share in the global orthopedic biomaterials market due to the increasing number of the target population, surge in the geriatric population, high adoption of advanced products associated with orthopedics, and the presence of a large number of pharmaceutical companies dealing in orthopedics. According to the Rural Health Information Hub 2020 report, in the United States, there are more than 46 million older adults aged 65 and up; by 2050, that number is expected to rise to nearly 90 million. The number of older adults is expected to increase by almost 18 million between 2020 and 2030. Thus, the rising geriatric population in the country is expected to boost the studied market due to the increasing prevalence of diseases like osteoarthritis and osteoporosis, which can seriously impair the well-being of elderly individuals.

The United States owns the largest share of the orthopedic biomaterials market in the North American region. Furthermore, well-established healthcare infrastructure, rising healthcare expenditure, and the high frequency of sports injuries in the United States fuel the market's growth. Likewise, in March 2020, the National Association for the Advancement of Orthotics and Prosthetics (NAAOP) issued an alert that state and local health authorities in the United States should consider orthopedic and prosthetic practices as an essential service that must remain accessible to patients in need of orthopedic and prosthetic care during the pandemic. Such developments have led to an increase in orthopedic surgical procedures within the region, thereby augmenting the demand for biomaterials during the pandemic phase.

Additionally, the approval from the regulatory authorities is also propelling the growth of the market. For instance, in June 2022, CeramTec received the United States Food and Drug Administration breakthrough device designation for a novel ceramic total knee replacement device. Such approvals are boosting the growth of the market.

Thus, owing to the abovementioned factors, the market is expected to show growth in the region.

Orthopedic Biomaterials Market Competitor Analysis

The orthopedic biomaterials market is moderately competitive and consists of several major players. Some companies currently dominating the market are Koninklijke DSM N.V., Zimmer Biomet, Stryker, Invibio Ltd., Evonik Industries, DePuy Synthes, Cam Bioceramics, Exactech, Inc., and Globus Medical Inc., among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Geriatric Population
    • 4.2.2 Growing Incidences of Musculoskeletal Injuries
  • 4.3 Market Restraints
    • 4.3.1 Reimbursement Policies
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value-USD million)

  • 5.1 By Material Type
    • 5.1.1 Polymers
    • 5.1.2 Ceramics & Bioactive Glasses
    • 5.1.3 Calcium Phosphate Cements
    • 5.1.4 Metal
    • 5.1.5 Others
  • 5.2 By Application
    • 5.2.1 Orthobiologics
    • 5.2.2 Joint Replacement/Reconstruction
    • 5.2.3 Viscosupplementation
    • 5.2.4 Orthopedic Implants
    • 5.2.5 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Koninklijke DSM N.V.
    • 6.1.2 Zimmer Biomet
    • 6.1.3 Stryker
    • 6.1.4 Invibio Ltd.
    • 6.1.5 Evonik Industries
    • 6.1.6 DePuy Synthes
    • 6.1.7 Cam Bioceramics
    • 6.1.8 Exactech, Inc
    • 6.1.9 Globus Medical Inc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS